Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis von Traboulsee, A, Simon, J H, Stone, L, Fisher, E, Jones, D E, Malhotra, A, Newsome, S D, Oh, J, Reich, D S, Richert, N, Rammohan, K, Khan, O, Radue, E-W, Ford, C, Halper, J, Li, D

Volltext

Progressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis von Sahraian, M. A., Radue, E.-W., Eshaghi, A., Besliu, S., Minagar, A.

Volltext

Black holes in multiple sclerosis: definition, evolution, and clinical correlations von Sahraian, M. A., Radue, E.-W., Haller, S., Kappos, L.

Volltext

Neuroimaging predictors of transition to psychosis—A systematic review and meta-analysis von Smieskova, R., Fusar-Poli, P., Allen, P., Bendfeldt, K., Stieglitz, R.D., Drewe, J., Radue, E.W., McGuire, P.K., Riecher-Rössler, A., Borgwardt, S.J.

Volltext

Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results von Comi, G., O'Connor, P., Montalban, X., Antel, J., Radue, E-W., Karlsson, G., Pohlmann, H., Aradhye, S., Kappos, L.

Volltext

Oral ponesimod in relapsing–remitting multiple sclerosis: a randomised phase II trial von Olsson, Tomas, Boster, Aaron, Fernández, Óscar, Freedman, Mark S, Pozzilli, Carlo, Bach, Doris, Berkani, Ouali, Mueller, Markus S, Sidorenko, Tatiana, Radue, Ernst-Wilhelm, Melanson, Maria

Volltext

The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis von Yaldizli, Ö., Penner, I.-K., Yonekawa, T., Naegelin, Y., Kuhle, J., Pardini, M., Chard, D. T., Stippich, C., Kira, J.-i., Bendfeldt, K., Amann, M., Radue, E.-W., Kappos, L., Sprenger, T.

Volltext

Oral fingolimod (FTY720) in multiple sclerosis : Two-year results of a phase II extension study von O'CONNOR, P, COMI, G, MONTALBAN, X, ANTEL, J, RADUE, E. W, DE VERA, A, POHLMANN, H, KAPPOS, L

Volltext

Standardized MR imaging protocol for multiple sclerosis : Consortium of MS centers consensus guidelines von SIMON, J. H, LI, D, WOLINSKY, J. S, TRABOULSEE, A, COYLE, P. K, ARNOLD, D. L, BARKHOF, F, FRANK, J. A, GROSSMAN, R, PATY, D. W, RADUE, E. W

Volltext

In Vivo Assessment and Visualization of Intracranial Arterial Hemodynamics with Flow-Sensitized 4D MR Imaging at 3T von Wetzel, S, Meckel, S, Frydrychowicz, A, Bonati, L, Radue, E.-W, Scheffler, K, Hennig, J, Markl, M

Volltext

Daclizumab high-yield process reduced the evolution of new gadolinium-enhancing lesions to T1 black holes in patients with relapsing−remitting multiple sclerosis von Radue, E.-W., Sprenger, T., Vollmer, T., Giovannoni, G., Gold, R., Havrdova, E., Selmaj, K., Stefoski, D., You, X., Elkins, J.

Volltext

Natalizumab reduces visual loss in patients with relapsing multiple sclerosis von BALCER, L. J, GALETTA, S. L, O'CONNOR, P. W, PHILLIPS, J. T, POLMAN, C. H, RADUE, E.-W, RUDICK, R. A, STUART, W. H, WAJGT, A, WEINSTOCK-GUTTMAN, B, WYNN, D. R, LYNN, F, CALABRESI, P. A, PANZARA, M. A, CONFAVREUX, C, GIOVANNONI, G, HAVRDOVA, E, HUTCHINSON, M, KAPPOS, L, LUBLIN, F. D, MILLER, D. H

Volltext

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL von Hutchinson, M., Kappos, L., Calabresi, P. A., Confavreux, C., Giovannoni, G., Galetta, S. L., Havrdova, E., Lublin, F. D., Miller, D. H., O’Connor, P. W., Phillips, J. T., Polman, C. H., Radue, E.-W., Rudick, R. A., Stuart, W. H., Wajgt, A., Weinstock-Guttman, B., Wynn, D. R., Lynn, F., Panzara, M. A.

Volltext

Management and outcome of CSF-JC virus PCR-negative PML in a natalizumabtreated patient with MS von KUHLE, J, GOSERT, R, FRANK, S, HIRSCH, H. H, BÜHLER, R, DERFUSS, T, SUTTER, R, YALDIZLI, Ö, RADUE, E.-W, RYSCHKEWITSCH, C, MAJOR, E. O, KAPPOS, L

Volltext

MR Angiography of Dural Arteriovenous Fistulas: Diagnosis and Follow-Up after Treatment Using a Time-Resolved 3D Contrast-Enhanced Technique von Meckel, S, Maier, M, Ruiz, D. San Millan, Yilmaz, H, Scheffler, K, Radue, E.-W, Wetzel, S.G

Volltext

Prediction of long-term disability in multiple sclerosis von Schlaeger, R, D’Souza, M, Schindler, C, Grize, L, Dellas, S, Radue, EW, Kappos, L, Fuhr, P

Volltext

Six-year follow-up of a case series with non-communicating syringomyelia in multiple sclerosis von Weier, K., Naegelin, Y., Amann, M., Magon, S., Mueller-Lenke, N., Radue, E.-W., Kappos, L., Stippich, C., Gass, A., Sprenger, T.

Volltext

Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis von Izquierdo, G, O’Connor, P, Montalban, X, von Rosenstiel, P, Cremer, M, de Vera, A, Sfikas, N, Francis, G, Radue, EW, Kappos, L

Volltext

Overt sentence production in event-related fMRI von Haller, Sven, Radue, E.W., Erb, Michael, Grodd, Wolfgang, Kircher, Tilo

Volltext

Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a von RUDICK, R. A, PACE, A, GALETTA, S. L, LUBLIN, F. D, RADUE, E.-W, RANSOHOFF, R. M, RANI, M. R. S, HYDE, R, PANZARA, M, APPACHI, S, SHROCK, J, MAURER, S. L, CALABRESI, P. A, CONFAVREUX, C

Volltext